India imposes new tracing requirements after cancer drug counterfeiting scandal

India has introduced new tracing requirements for cancer drugs in response to a significant counterfeiting scandal. The move aims to strengthen oversight and prevent the distribution of counterfeit medications in the pharmaceutical supply chain.

The fresh regulations mandate enhanced tracking mechanisms to verify the authenticity of cancer medications. This step underscores growing concerns over drug counterfeiting and its impact on patient safety and healthcare delivery across the nation.